OSCR

Investigating the prognostics and theranostic cell cycle-related genes of Hinokinin in high-grade glioma: an integrated network pharmacology, bioinformatics, and molecular docking approach.

Overview

Authors: Oukhdouch Anass1,2, Nadir Youssef3, Salman El mostafa4,5, Jebhi Khalid6, Zinbi Basma2, Sellami Souad2, Rais Hanane1,2
  1. Morphoscience Research Laboratory, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco
  2. Anatomic Pathology Department, Biopathology laboratory, Clinical Research Center, University Hospital Mohammed VI, Marrakech, Morocco
  3. Biological Engineering Laboratory, Faculty of Science and Technology, Sultan Moulay Slimane University, Beni Mellal 23000, Morocco
  4. Genetics department, Clinical Research Center, University Hospital Mohammed VI, Marrakech, Morocco
  5. Research Center for Childhood, Health and Sustainable Development, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco
  6. Histology, Embryology and Cytogenetics Laboratory, Faculty of Medicine and Pharmacy, Cadi Ayyad University, Marrakech, Morocco
Journal: Journal, genetic engineering & biotechnology, volume 24, issue 3, article 100724
Dates: received 14 January 2026; accepted 30 May 2026; published online 17 June 2026; in print September 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.1016/j.jgeb.2026.100724 · PMID 42749405 · PMCID PMC13311168 · OpenAlex W7165035347
Open access: gold, a free copy (OpenAlex)
Status: data only
Categories: other condition (population), cellular / molecular (subfield)
Methods: Statistics
Keywords: Glioblastoma, Hinokinin, Cell-cycle kinases, Network pharmacology, Molecular docking
Topic: Berberine and alkaloids research (Pharmacology, Medicine), according to OpenAlex
Citations: not cited yet (Europe PMC); 50 references in the paper

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Datasets cited

Other data links

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 7 authors, 5 keywords, 50 references.

Cite

This paper

Anass, O., Youssef, N., El mostafa, S., Khalid, J., Basma, Z., Souad, S., & Hanane, R. (2026). Investigating the prognostics and theranostic cell cycle-related genes of Hinokinin in high-grade glioma: an integrated network pharmacology, bioinformatics, and molecular docking approach. Journal, genetic engineering & biotechnology, 24(3), 100724. https://doi.org/10.1016/j.jgeb.2026.100724

BibTeX

@article{anass2026investigating,
author = {Anass, Oukhdouch and Youssef, Nadir and El mostafa, Salman and Khalid, Jebhi and Basma, Zinbi and Souad, Sellami and Hanane, Rais},
title = {{Investigating the prognostics and theranostic cell cycle-related genes of Hinokinin in high-grade glioma: an integrated network pharmacology, bioinformatics, and molecular docking approach}},
journal = {Journal, genetic engineering \& biotechnology},
year = {2026},
month = jun,
volume = {24},
number = {3},
pages = {100724},
publisher = {Academy of Scientific Research and Technology, Egypt},
issn = {1687-157X},
doi = {10.1016/j.jgeb.2026.100724},
url = {https://doi.org/10.1016/j.jgeb.2026.100724},
pmid = {42749405},
pmcid = {PMC13311168}
}

RIS

TY - JOUR
AU - Anass, Oukhdouch
AU - Youssef, Nadir
AU - El mostafa, Salman
AU - Khalid, Jebhi
AU - Basma, Zinbi
AU - Souad, Sellami
AU - Hanane, Rais
TI - Investigating the prognostics and theranostic cell cycle-related genes of Hinokinin in high-grade glioma: an integrated network pharmacology, bioinformatics, and molecular docking approach
T2 - Journal, genetic engineering & biotechnology
J2 - J Genet Eng Biotechnol
PY - 2026
DA - 2026/06/17
VL - 24
IS - 3
SP - 100724
SN - 1687-157X
PB - Academy of Scientific Research and Technology, Egypt
DO - 10.1016/j.jgeb.2026.100724
UR - https://doi.org/10.1016/j.jgeb.2026.100724
LA - en
ER -

CSL-JSON

{
"id": "10.1016/j.jgeb.2026.100724",
"type": "article-journal",
"title": "Investigating the prognostics and theranostic cell cycle-related genes of Hinokinin in high-grade glioma: an integrated network pharmacology, bioinformatics, and molecular docking approach",
"container-title": "Journal, genetic engineering & biotechnology",
"author": [
{
"family": "Anass",
"given": "Oukhdouch"
},
{
"family": "Youssef",
"given": "Nadir"
},
{
"family": "El mostafa",
"given": "Salman"
},
{
"family": "Khalid",
"given": "Jebhi"
},
{
"family": "Basma",
"given": "Zinbi"
},
{
"family": "Souad",
"given": "Sellami"
},
{
"family": "Hanane",
"given": "Rais"
}
],
"container-title-short": "J Genet Eng Biotechnol",
"volume": "24",
"issue": "3",
"page": "100724",
"DOI": "10.1016/j.jgeb.2026.100724",
"PMID": "42749405",
"PMCID": "PMC13311168",
"ISSN": "1687-157X",
"publisher": "Academy of Scientific Research and Technology, Egypt",
"URL": "https://doi.org/10.1016/j.jgeb.2026.100724",
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
17
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.32604/or.2026.079221
Single-Cell Sequencing Reveals the Heterogeneity of Glioma and Identifies IGFBP2 as A Potential Therapeutic Target.
Journal: Oncology research
In common: other condition, cellular / molecular, 5 references
[2] doi:10.1016/j.apsb.2026.06.016
Rhynchophylline rewires DLAT lipoylation <i>via</i> conformational control to reverse mitochondrial bioenergetic collapse against dopaminergic neuronal injury.
Journal: Acta pharmaceutica Sinica. B
In common: rcsb.org/structure/https:, cellular / molecular
[3] doi:10.1016/j.jbc.2026.113091
Structure and enzymology of glutaminase S482C and H461L variants associated with excess brain glutamate and neurological disease.
Journal: The Journal of biological chemistry
In common: rcsb.org/structure/https:, cellular / molecular
[4] doi:10.1016/j.jbc.2026.111471
Oxidative stress impairs processive motility of the axonal transport motor KIF1A.
Journal: The Journal of biological chemistry
In common: rcsb.org/structure/https:, cellular / molecular
[5] doi:10.1016/j.isci.2026.115554
Computationally guided discovery of Ly6e/LY6E-dependent AAV capsid variants.
Journal: iScience
In common: rcsb.org/structure/https:, cellular / molecular
[6] doi:10.1038/s41467-026-76587-0 [code]
Uncovering the signaling networks of disseminated glioblastoma cells in vivo with INSIGHT.
Journal: Nature communications
In common: other condition, cellular / molecular, 3 references
[7] doi:10.3390/ijms27167240
1-Piperidine Propionic Acid Inhibits PAR2/SerpinB3 Signaling and Reduces Glioblastoma Tumor Aggressiveness.
Journal: International journal of molecular sciences
In common: other condition, cellular / molecular, 3 references
[8] doi:10.1038/s41586-026-10612-6 [code]
Acquired genetic and cell-state changes in IDH-mutant glioma progression.
Journal: Nature
In common: other condition, cellular / molecular, 3 references
[9] doi:10.1158/2767-9764.crc-25-0579 [code]
Glioblastoma Subtypes Exhibit Distinct Migration Mechanics and Immune Responses.
Journal: Cancer research communications
In common: other condition, 3 references
[10] doi:10.1186/s12935-026-04341-z
From bioinformatics to bedside: PPBP drives glioblastoma progression under hypoxia via CXCR2/PI3K/Akt signaling and is targetable by Oenothein B.
Journal: Cancer cell international
In common: other condition, cellular / molecular, 2 references

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.